Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 14 02 2019
accepted: 09 07 2019
revised: 16 06 2019
pubmed: 19 7 2019
medline: 11 11 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), mean platelet volume (MPV), and red cell distribution width (RDW) may potentially reflect inflammatory status in systemic autoimmune diseases. The aim of this study is to investigate the association between these proposed markers and disease manifestations, activity, and severity in systemic sclerosis (SSc). We conducted a cross-sectional study of 69 systemic sclerosis (SSc) patients and 50 healthy volunteers in a single center. Adult patients with SSc and healthy controls were compared in terms of NLR, MLR, MPV, RDW, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Venous blood samples were drawn after at least 8 h of fasting in the morning. Extension of skin fibrosis was evaluated by using modified Rodnan skin score (mRSS). Disease severity and activity were assessed by Medsger disease severity and European Scleroderma Trials and Research Group (EUSTAR) disease activity scores, respectively. Associations of disease manifestations, clinical, laboratory, and capillaroscopic findings, mRSS, and the disease activity and severity scores with the proposed hematological markers were evaluated. Multiple regression models were generated for significant associations. The neutrophil number was higher (p = 0.004) and lymphocyte number was lower (p < 0.001) in SSc group compared to controls. SSc group also had higher NLR, MLR, and RDW. In multiple logistic regression, only the NLR (regression coefficient = 3.49, p = 0.031) and CRP (regression coefficient = 0.17, p = 0.037) remained significantly different between SSc and healthy control groups (Cox and Snell R Globally available and inexpensive hematological tests, particularly the NLR and MLR, may be associated with vascular and cutaneous manifestations as well as disease activity and severity in SSc.Key Points• Monocyte count itself independently predicted higher activity and severity scores in SSc.• Globally available and inexpensive hematological markers, particularly the NLR and MLR, may have an association with vascular and cutaneous manifestations as well as disease activity and severity in patients with SSc.

Identifiants

pubmed: 31317426
doi: 10.1007/s10067-019-04685-0
pii: 10.1007/s10067-019-04685-0
doi:

Substances chimiques

Biomarkers 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-83

Références

J Am Coll Cardiol. 2004 Sep 1;44(5):959-66
pubmed: 15337204
Mod Rheumatol. 2016;26(3):372-6
pubmed: 26403379
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14
pubmed: 22556030
Stroke. 2004 Jul;35(7):1688-91
pubmed: 15143290
J Rheumatol. 1995 Jul;22(7):1281-5
pubmed: 7562759
J Inflamm (Lond). 2011 Nov 03;8(1):30
pubmed: 22047640
Semin Arthritis Rheum. 2010 Feb;39(4):285-93
pubmed: 19782387
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Clin Biochem. 2014 Dec;47(18):287-90
pubmed: 25204965
Med Princ Pract. 2016;25(6):510-516
pubmed: 27348861
Ann Rheum Dis. 2008 Jan;67(1):59-63
pubmed: 17519276
Int J Rheum Dis. 2015 Sep;18(7):731-5
pubmed: 25900081
Clin Chem Lab Med. 2011 Dec 17;50(4):635-41
pubmed: 22505527
Clin Rheumatol. 2017 Jul;36(7):1649-1654
pubmed: 28293753
Blood Press. 2013 Apr;22(2):80-5
pubmed: 22835009
Inflammation. 2014 Feb;37(1):100-6
pubmed: 23996103
Lancet. 1991 Dec 7;338(8780):1409-11
pubmed: 1683417
Clin Lab. 2015;61(3-4):269-73
pubmed: 25974992
Clin Rheumatol. 2018 Apr;37(4):979-985
pubmed: 29164429
Ann Rheum Dis. 2017 Jan;76(1):270-276
pubmed: 27621285
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
West Indian Med J. 2015 May 06;65(1):165-169
pubmed: 26645595
Arthritis Rheum. 2003 Aug;48(8):2246-55
pubmed: 12905479
J Clin Lab Anal. 2016 Sep;30(5):597-601
pubmed: 26666737
Haematologica. 2014 Jan;99(1):194-200
pubmed: 23894011
Br J Haematol. 2013 Jun;161(5):715-25
pubmed: 23530521
J Rheumatol. 2000 Jan;27(1):155-60
pubmed: 10648032
Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42-6
pubmed: 12889222
Atherosclerosis. 2010 Dec;213(2):586-91
pubmed: 20940069
Br J Haematol. 1983 Jul;54(3):337-52
pubmed: 6860588
APMIS. 2017 Oct;125(10):863-871
pubmed: 28766758
Ann Rheum Dis. 2011 Feb;70(2):366-72
pubmed: 21068092
Blood. 2004 Mar 15;103(6):2096-104
pubmed: 14630798
J Clin Invest. 2005 Dec;115(12):3378-84
pubmed: 16322783
Med Sci Monit. 2005 Aug;11(8):CR387-92
pubmed: 16049381
Blood. 2010 Oct 21;116(16):e74-80
pubmed: 20628149
Am Heart J. 2009 Oct;158(4):659-66
pubmed: 19781428
Arch Pathol Lab Med. 2009 Apr;133(4):628-32
pubmed: 19391664
Rheumatology (Oxford). 2014 Aug;53(8):1439-45
pubmed: 24659752
Arthritis Rheum. 1999 Dec;42(12):2660-5
pubmed: 10616015
Rheumatology (Oxford). 2000 Nov;39(11):1269-71
pubmed: 11085808
Hemodial Int. 2018 Jan;22(1):82-92
pubmed: 28403540
Int Immunopharmacol. 2016 Jul;36:94-99
pubmed: 27111516
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1375-80
pubmed: 23401350

Auteurs

Müçteba Enes Yayla (ME)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey. enesyayla@hotmail.com.

Ufuk İlgen (U)

Department of Rheumatology, Faculty of Medicine, Trakya University, Edirne, Turkey.

İlyas Ercan Okatan (İE)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Emine UsluYurteri (E)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Murat Torgutalp (M)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Ayşe Bahar Keleşoğlu Dinçer (AB)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Emine Gözde Aydemir Gülöksüz (EG)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Serdar Sezer (S)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Tahsin Murat Turgay (TM)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Gülay Kınıklı (G)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Aşkın Ateş (A)

Department of Rheumatology, Faculty of Medicine, Ankara University, Sıhhıye, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH